Laplace Interventional
MN - PlymouthMedical Devices
Focus: Laplace Interventional is a medical device company focused on transcatheter tricuspid valve replacement, addressing a high-mortality cardiovascular condition with limited treatment options. The company operates from Plymouth, Minnesota with a focused pipeline in interventional cardiology.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Laplace Interventional
AI assessmentNot HiringNo open roles listed right now. Follow Laplace Interventional to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Laplace TTVR System
Tricuspid RegurgitationClinical Trials (1)
NCT06183684Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
N/AHelp build intelligence for Laplace Interventional
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.